Table 2:

Comparative overview of MR imaging biomarkers for adult and pediatric cohorts regarding genetic entity discrimination

Adult Cohort Imaging Criteria (n = 28)P ValueCorrespondenceP ValuePediatric Cohort Imaging Criteria (n = 47)a
Hemorrhageb.04bNobNSBlood products
Edema volumeb.02bNobNSEdema present
Hydrocephalusb.03bNANANA
Chang M-stage ≥2b (Chang on CET1WI plus spinal tap).02bNANANA
Contact with lower rhombic lipb.03bNANANA
Chang T-stage >T2 on T2WIb.01bNANANA
Contact with fourth ventricleb.02bPseudocorrespondence<.005bMidline/fourth ventricleb
Infiltration of vermis.80Nob
Cysts.82Both NSNSCyst
Contrast-enhancement homogeneity.29Both NSNSEnhancement pattern solid
Infiltration of cerebellar hemispheres.08Nob<.005bCerebellar hemisphereb
Contact with cerebellopontine angle1.0Nob<.005bContact with cerebellopontine angleb
Enhancement pattern.81Nob<.005bEnhancement minimal to noneb
Sharp margins.63Nob.03bIll-defined marginsb
NANANANSEnhancement pattern, other
  • Note:—NA indicates not available (parameter not analyzed); NS, criterion not significantly unbalancedly distributed, hence not identified a biomarker by Perreault et al.14

  • a Pediatric cohort: discovery cohort of Perreault el al.14 No identical MR imaging biomarkers could be identified among imaging criteria of both cohorts.

  • b MR imaging biomarkers that were identified by significantly imbalanced distribution between genetic entities.